UPDATE: BofA/Merrill Lynch Starts United Therapeutics Corp. (UTHR) at Underperform on Competition, Unclear Growth Outlook
Tweet Send to a Friend
(Updated - December 3, 2019 6:25 AM EST)
(update analyst name, comment)BofA/Merrill Lynch analyst Geoff Meacham initiates coverage on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(update analyst name, comment)BofA/Merrill Lynch analyst Geoff Meacham initiates coverage on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
